| NCT04052776 | Acute Effects of Pharmacological Neuromodulation on Leg Motor Activity in Patients With SCI Treated With EES | Centre Hospitalier Universitaire Vaudois | | - Age 18 - 65 yrs
- Level C1-T10
AIS A, B, C, D- ≥ 1 months
- Only participants who have completed the main phase of the STIMO study will be invited to participate in this trial.
- In addition, the participant must:
- have a spinal cord injury for at least 12 months.
- have a neurological level of injury at T10 or above.
- have one of the following ASIA impairment scale (AIS):
- AIS A: complete; no feeling or movement below the injury
- AIS B: incomplete; have some feeling, but no movement, below the injury
- AIS C: incomplete; at least some feeling and mostly weak movement below the injury
- AIS D: incomplete; at least some feeling and, some weak but mostly stronger movement below the injury)
- be between the ages of 18-65 years.
| Ended | 3 | PHASE1 | Technology | General health | | | 11 September 2020 | 12 August 2019 | 1 | |
| NCT04049994 | Immunomodulation Therapy for Urinary Tract Infections | Swiss Paraplegic Research, Nottwil | | - Age 18 - 60 yrs
- Level C1-S5
AIS A, B, C, D- 1 months - 3 months
| Ended | 24 | PHASE4 | Drug | General health | | | 01 June 2020 | 08 August 2019 | 1 | |
| NCT04029974 | Speed of Robotic Leg Movements and Orthostatic Hypotension in Subacute SCI | Methodist Rehabilitation Center | | - Age 16 - 70 yrs
- Level C1-S5
AIS C- ≤ 12 weeks
| Active | 35 | NA | Technology | General health | | | 20 August 2019 | 23 July 2019 | 1 | |
| NCT04008160 | Intelligent Underwear (IU) in Paraplegics | Swiss Paraplegic Research, Nottwil | | - Age 18 - 50 yrs
- Level C1-S5
AIS A, B, C, D- ≤ 50 years
| Ended | 0 | | Technology | Skin health | | | 01 October 2022 | 05 July 2019 | 1 | |
| NCT03987126 | Prebiotics for Spinal Cord Injury Patients With Bowel and Bladder Dysfunction | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | | - Age ≥ 18 yrs
- Level C1-S5
AIS A, B, C, D- ≥ 3 months
| Ended | 30 | PHASE3 | Drug | Bowel health | | | 27 January 2021 | 14 June 2019 | 1 | |
| NCT03989440 | AXER-204 in Participants With Chronic Spinal Cord Injury | ReNetX Bio, Inc. | | - Age 18 - 65 yrs
- Level C1-C8
AIS A, B, C, D- 1 years - 65 years
- have a spinal cord injury for at least 1 year.
- have a cervical spinal cord injury.
- have “serious” neurological deficits in upper extremity motor function (upper extremity motor score between 4-36 out of 50).
- be between the ages of 18 and 65 years.
| Ended | 52 | PHASE1, PHASE2 | Drug | General health | | | 16 July 2019 | 18 June 2019 | 6 | |
